South East Asia Hemp Derived CBD Oil Market Size & Outlook, 2026-2034

South East Asia Hemp Derived CBD Oil Market Insights

According to Deep Market Insights analysis, the South East Asia Hemp Derived CBD Oil Market size was USD 4.94 Million in 2025 and is projected to reach USD 14.6 Million by 2034.
The South East Asia market is projected to grow at a CAGR of 12.6% between 2026 and 2034.
By segment, Full-spectrum CBD oil emerged as the largest By Type in terms of market size in 2025.
Full-spectrum CBD oil is anticipated to remain the most attractive By Type segment, recording the fastest growth during the forecast period.

In 2025, South East Asia accounted for 2.06% of the global Hemp Derived CBD Oil Market size.
By 2034, United States is expected to lead the global Hemp Derived CBD Oil Market in terms of market size.
Within Asia Pacific, China is projected to dominate the regional Hemp Derived CBD Oil Market size by 2034.
Japan is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 20.4 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 4.94 Million
Market Size In 2034	USD 14.6 Million
Largest segment	Full-spectrum CBD oil
Units	Revenue in USD Million
CAGR	12.6% (2026-2034)
Segmnetation Covered
By Type	Full-spectrum CBD oil Broad-spectrum CBD oil CBD isolate oil Organic CBD oil
By Form	Tinctures Capsules Topicals Edibles
By Application	Pain relief Anxiety & stress Wellness Sleep support
By Distribution Channel	Pharmacies Online retail Dispensaries Health stores
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Full-spectrum CBD oil	XX.x	XX.x	XX.x	2.38	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Broad-spectrum CBD oil	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
CBD isolate oil	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Organic CBD oil	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Form	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Tinctures	XX.x	XX.x	XX.x	2.24	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Capsules	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Topicals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Edibles	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pain relief	XX.x	XX.x	XX.x	2.11	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Anxiety & stress	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Wellness	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Sleep support	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Distribution Channel	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmacies	XX.x	XX.x	XX.x	2.32	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online retail	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dispensaries	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Health stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x